UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
February 10, 2020
Accession Number:
0001437749-20-001911
Submission Type:
POS AM
CIK:
0001389545
Company Name:
NovaBay Pharmaceuticals, Inc.
File Number:
333-230672